Banner - NPPA Connect

|Poll|December 20, 2021

POLL: Should iPLEDGE Program be Discontinued?

Author(s)Dermatology Times Staff

Click here to answer this week's poll.

Should iPLEDGE Program be Discontinued?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Multimodal PRP, Laser, and LED Protocol Explored for Acne Sequelae

ByShannon Heaning, Content Associate

September 9th 2026

Ultrapulse CO2 Laser Therapy Shows Promise for Chronic Acne Conglobata Sequelae

ByMarie Bosslett, Assistant Editor

September 9th 2026

Dermatology Times Cutaneous Oncology Workshop to Bring Hands-On Cutaneous Oncology Education to Tampa

ByShannon Heaning, Content Associate

September 9th 2026

Journal Digest: September 9, 2026

ByMarie Bosslett, Assistant Editor

September 9th 2026

Former CDC Director Robert Redfield Joins Turn Therapeutics as Chief Scientific Officer

ByShannon Heaning, Content Associate

September 9th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Biologic Therapy Linked to Lower 10-Year MACE Risk Across Racial Groups in Psoriasis

Former CDC Director Robert Redfield Joins Turn Therapeutics as Chief Scientific Officer

Body Weight, Not BMI, Associated With Brodalumab Response Trajectory in Plaque Psoriasis

Journal Digest: September 9, 2026

Ultrapulse CO2 Laser Therapy Shows Promise for Chronic Acne Conglobata Sequelae